Free US stock correlation to major indices and sector benchmarks for performance attribution analysis. We help you understand how your portfolio moves relative to broader market benchmarks.
As of April 6, 2026, Celcuity Inc. (CELC) trades at $114.14, posting a 1.34% gain in the current session. This analysis evaluates key technical levels, recent market context, and potential price scenarios for the clinical-stage biotechnology firm, which focuses on precision oncology therapies. No recent earnings data is available for CELC at the time of writing, so price action has been driven primarily by technical flows, sector sentiment, and broader market dynamics in recent weeks. The key ta
Is Celcuity (CELC) Stock Ready to Drop | Price at $114.14, Up 1.34% - Bearish Pattern
CELC - Stock Analysis
4106 Comments
976 Likes
1
Ashilee
Loyal User
2 hours ago
Comprehensive US stock balance sheet stress testing and liquidity analysis for downside risk assessment and crisis preparedness planning. We model different scenarios to understand how companies would perform under adverse conditions and economic stress. We provide stress testing, liquidity analysis, and downside scenario modeling for comprehensive coverage. Understand downside risks with our comprehensive stress testing and liquidity analysis tools for risk management.
👍 130
Reply
2
Melzina
Community Member
5 hours ago
Indices are consolidating after reaching short-term overbought conditions.
👍 23
Reply
3
Jahiya
Returning User
1 day ago
I read this like it was going to change my life.
👍 247
Reply
4
Dondrey
Consistent User
1 day ago
Price trends suggest a mixture of consolidation and selective upward movement across key sectors.
👍 184
Reply
5
Zamarie
Regular Reader
2 days ago
I guess timing just wasn’t right for me.
👍 28
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.